Literature DB >> 28663673

Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients.

Sunil Taneja1, Pramod Kumar1, Vikas Gautam2, Ajay Duseja1, Virendra Singh1, Radha K Dhiman1, Yogesh Chawla1.   

Abstract

INTRODUCTION: Burkholderia cepacia complex (Bcc) is non-fermenting Gram-negative bacillus and has been rarely reported to cause spontaneous bacterial peritonitis (SBP) in decompensated cirrhosis.
OBJECTIVE: This study was done to evaluate the clinical presentation of cirrhotic patients with SBP due to Bcc and to determine its impact on clinical outcome.
METHODS: This is a retrospective, observational study conducted during the period from 1st January 2013 through 31st March 2015. Medical records and microbiology laboratory files were reviewed to identify all cases of Bcc associated SBP among patients hospitalized at the liver intensive care unit and analyzed.
RESULTS: During the study period, out of 252 SBP patients, 11 (4.3%) patients with a positive ascitic fluid culture for Bcc were identified. Pain abdomen was the predominant symptom present in 9 (81%) patients followed by hepatic encephalopathy in 7 (63%) patients. Acute kidney injury (AKI) was universally present, seen in 6 (54%) patients at the time of presentation and 4 (36%) patients developed AKI during hospital stay. The mean CTP score was 11.2 ± 1.1 (10-13), and the mean MELD was 24.3 ± 5.9 (14-35). The mean SOFA and APACHE II score at presentation were 11 ± 4.2 (4-18) and 19.4 ± 5.2 (11-28), respectively. A total of 8 (72%) patients (6-ACLF, 2-NASH) succumbed to the illness during hospitalization due to severe sepsis and multiorgan dysfunction and 3 (27%) patients are doing well on follow-up after 3 months.
CONCLUSION: SBP caused by Bcc has been rarely reported in cirrhotic patients. This organism is intrinsically resistant to third generation cephalosporins, which are the initial antibiotic of choice for SBP patients, hence associated with multi organ failure and high mortality rates.

Entities:  

Keywords:  AKI, acute kidney injury; APACHE II, Acute Physiology and Chronic Health Evaluation (APACHE); APASL, Asia Pacific Association for the Study of Liver; Bcc, Burkholderia cepacia complex; CSLI, The Clinical and Laboratory Standards Institute; CTP, Child Turcotte Pugh Score; HCV, Hepatitis C virus; ICU, intensive care unit; NASH, non-alcoholic steatohepatitis; PGIMER, Postgraduate Institute of Medical Education and Research; SBP, spontaneous bacterial infection; SIRS, systemic inflammatory response syndrome; SOFA, The Sequential Organ Failure Assessment; UTI, urinary tract infection; cirrhosis; infection; spontaneous bacterial peritonitis

Year:  2016        PMID: 28663673      PMCID: PMC5478935          DOI: 10.1016/j.jceh.2016.08.008

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  20 in total

Review 1.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

2.  Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India.

Authors:  Vikas Gautam; Anita Arora; S K Madhup; Anindita Das; P Vandamme; Kusum Sharma; Vipin Koushal; Deepak Bansal; Meera Sharma; R K Garg; Sudesh Rana; R K Marwaha; Pallab Ray
Journal:  Indian J Med Res       Date:  2010-06       Impact factor: 2.375

3.  In vitro activity of doripenem against Burkholderia cepacia complex isolates from non-cystic fibrosis patients.

Authors:  Lipika Singhal; Vikas Gautam; Mandeep Kaur; Pallab Ray
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

Review 4.  Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management.

Authors:  C Guarner; B A Runyon
Journal:  Gastroenterologist       Date:  1995-12

5.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

6.  Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.

Authors:  Yong-Tao Li; Cheng-Bo Yu; Jian-Rong Huang; Zheng-Ji Qin; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

7.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

8.  Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients.

Authors:  D B Hurwich; K D Lindor; J E Hay; J B Gross; D Kaese; J Rakela
Journal:  Am J Gastroenterol       Date:  1993-08       Impact factor: 10.864

9.  Two cases of Burkholderia cenocepacia in septicemic patients.

Authors:  Vikas Gautam; Pallab Ray; Anindita Das; Peter Vandamme; Pankaj Malhotra; Subhash Varma; Rajesh Vijayvergiya; Jharna Mandal; Nidhi Garg
Journal:  Jpn J Infect Dis       Date:  2008-03       Impact factor: 1.362

10.  Two novel clinical presentations of Burkholderia cepacia infection.

Authors:  Chiranjoy Mukhopadhyay; Anudita Bhargava; Archana Ayyagari
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.